The NAVETA obesity consensus tool: a multidimensional framework for clinical and patient-reported outcome assessment

The NAVETA Obesity Consensus Tool represents the first consensus-based, patient-centered framework for standardized outcome assessment in obesity care in Spain. By combining validated PROMs, PREMs, and clinical variables within a digital platform, it provides a structured foundation for individualized follow-up, real-world data generation, and benchmarking across centers. This initiative supports the transition toward precision and value-based obesity management-particularly in the context of GLP-1 receptor agonist therapy-and lays the groundwork for a national outcome-based registry aligned with international standards.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-01-08
DOI
https://doi.org/10.3389/fendo.2025.1731194
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The NAVETA obesity consensus tool: a multidimensional framework for clinical and patient-reported outcome assessment

Salvador Herrera-Pérez, María Antonia Maestre-Fullana, Josep Lluch-Taltavull, Gabriel Mercadal-Orfila et al.
Frontiers in Endocrinology
Bariatric Surgery and Outcomes
article

The NAVETA obesity consensus tool: a multidimensional framework for clinical and patient-reported outcome assessment

Salvador Herrera-Pérez, María Antonia Maestre-Fullana, Josep Lluch-Taltavull, Gabriel Mercadal-Orfila, José María García, Guillem Cuatrecasas
article en

Abstract

The NAVETA Obesity Consensus Tool represents the first consensus-based, patient-centered framework for standardized outcome assessment in obesity care in Spain. By combining validated PROMs, PREMs, and clinical variables within a digital platform, it provides a structured foundation for individualized follow-up, real-world data generation, and benchmarking across centers. This initiative supports the transition toward precision and value-based obesity management-particularly in the context of GLP-1 receptor agonist therapy-and lays the groundwork for a national outcome-based registry aligned with international standards.

Frontiers in EndocrinologyVol. 16
Universitat Oberta de Catalunya (ES), Universitat Pompeu Fabra (ES), Valencian International University (ES), Hospital Quirón Teknon (ES), Universidad Internacional (MX), Fundación Hospital Manacor (ES), Hospital General Mateu Orfila (ES), Universitat de les Illes Balears (ES)
Eli Lilly and Company, Novo Nordisk
Zero hunger
Openalex Percentile: Top 97%
Bariatric Surgery and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.